Janet Fisher to Immunotherapy
This is a "connection" page, showing publications Janet Fisher has written about Immunotherapy.
Connection Strength
0.127
-
Regulatory T-cells and associated pathways in metastatic renal cell carcinoma (mRCC) patients undergoing DC-vaccination and cytokine-therapy. PLoS One. 2012; 7(10):e46600.
Score: 0.089
-
ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy. J Immunother Cancer. 2020 04; 8(1).
Score: 0.037